92373 ⎘
Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
Sub-classes:Process for Manufacturing Pibrentasvir Active Drug Substance
#2PRODUCTION METHOD FOR FLUOROMETHYL DERIVATIVE
#3METHOD FOR PREPARING 4-NITRO-2-(TRIFLUOROMETHYL)ACETOPHENONE AND APPLICATION THEREOF
#4PHARMACOLOGICAL AGENTS FOR PREVENTING AND TREATING CATARACTS AND PRESBYOPIA EYE DISEASES
#5METHOD FOR PREPARING CHIRAL NITRO DERIVATIVES USING ORGANIC CHIRAL CATALYST COMPOUNDS AND ECO-FRIENDLY SOLVENTS
#6USE OF SMALL MOLECULE INHIBITORS TO KLF10 FOR MODULATION OF T REGULATORY CELLS AND CANCER IMMUNOTHERAPY
#7Inhibition of respiratory complex III by ligands that interact with a regulatory switch
#8Production method for fluoromethyl derivative
#9Process for Manufacturing Pibrentasvir Active Drug Substance
#10Nuclear receptor modulators and their use for the treatment and prevention of cancer
#11Method for preparing 3-trifluoromethyl chalcones
#12Method for preparing 3-trifluoromethyl chalcones
#13Process for the preparation of 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone and derivatives thereof
#14Method for preparing 3-trifluoromethyl chalcones
#15Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy
#16INHIBITORS OF THE WNT SIGNALLING PATHWAYS
#17Method of manufacturing nitrone compound
#18Method for preparing 3-trifluoromethyl chalcones
#191,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#20Compounds
#21Synthetic analogues of xanthohumol
#22Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
#23Method for preparing 3-trifluoromethyl chalcones
#24Fluorine-containing compound, substrate for pattern formation, photodegradable coupling agent, pattern formation method, and compound
#25NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES
#26Preparation of fingolimod and its salts
#27Nuclear receptor modulators and their use for the treatment and prevention of cancer
#28Method for preparing 3-trifluoromethyl chalcones
#291,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient
#30Method for preparing 5-haloalkyl-4, 5-dihydroisoxazole derivatives
#31NOVEL PROCESS FOR PREPARING PHENYLCYCLOPROPYLAMINE DERIVATIVES USING NOVEL INTERMEDIATES
#32Benzylidene indanones and processes for preparation and use thereof
#33Synthesis and applications of soluble pentacene precursors and related compounds
#34Method for enhancing heterogeneous asymmetric selectivity and catalytic activity
#35Phosphorylated and branched dihydroxy-pentane-dione (DPD) analogs as quorum sensing inhibitors in bacteria
#36METHOD FOR PREPARING 5-HALOALKYL-4, 5-DIHYDROISOXAZOLE DERIVATIVES
#37Synthetic flavonoids and pharmaceutical compositions and therapeutic methods of treatment of HIV infection and other pathologies
#38Detection of disease related genes
#39Processes for the synthesis of gamma nitrocarbonyl and gamma dicarbonyl compounds and their pyrrole derivatives
#40Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
#41Bioreactive agents
#42Process for the production of benzofurans
#43Phosphine ligands for catalytic reactions
#44Michael reaction with recovery of the catalyst
#451-adamantyl chalcones for the treatment of proliferative disorders
#46Process for the manufacture of 4-fluoro-2-methyl-1H-indol-5-ol
#47Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
#48BIOREACTIVE AGENTS
#49Process for the manufacturing of betamimetics
#50THERAPEUTIC AGENT FOR CANCER RESISTANT TO PROTEASE INHIBITOR
#51Friedel-Crafts acylation for the synthesis of aryl- and heteroaryl-(3-ethyl-4-nitrophenyl)-methanones
#52Therapeutic agent for Alzheimer's disease
#53Method for preparing 3-trifluoromethyl chalcones
#54Processes for the synthesis of γ nitrocarbonyl and γ dicarbonyl compounds and their pyrrole derivatives
#55Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
#56NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY
#57Substituted tetralins as selective estrogen receptor-β agonists
#58Heterocyclic amide derivatives useful as microbiocides
#59Heterocyclic a amide derivatives useful as microbiocides
#60Curcumin analogues and uses thereof
#61Bioreactive Agents
#62Bis(arylmethylidene)acetone compound, anti-cancer agent, carcinogenesis-preventive agent, inhibitor of expression of Ki-Ras, ErbB2, c-Myc and Cycline D1, β-catenin-degrading agent, and p53 expression enhancer
#636,8,10-undecatrien-3-one or 6,8,10-undecatrien-4-one, and aroma compositions
#64Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
#65Methods to prepare penta-1,4-dien-3-ones and substituted cyclohexanones and derivatives with antitumoral and antiparasitic properties, the compounds and their uses
#66Method of using rhodium quinonoid catalysts
#671-adamantyl chalcones for the treatment of proliferative disorders
#68Hsp90 family protein inhibitors
#69Synthesis and applications of soluble pentacene precursors and related compounds
#70Benzoic Acid Derivatives that are Modulators or Agonists of GlyR
#71Bioreactive agents
#72Indene derivatives, their preparation and use as medicaments
#73Allylic oxidations catalyzed by dirhodium catalysts under aqueous conditions
#74Organocataslysts and methods of use in chemical synthesis
#75Substituted phenanthrene diketo acids and uses therefor
#76BIOREACTIVE AGENTS
#77DECALINE-DERIVED COMPOUNDS AS PHARMACEUTICALLY ACTIVE AGENTS
#781-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
#79Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
#80Illudin analogs useful as antitumor agents
#812-C-Substituted Propane-1,3-Dicarbonyl Compounds and Their Use in Neutralising Malodour
#82Propofol analogs, process for their preparation, and methods of use
#83Heterocyclic amide derivatives useful as microbiocides
#84Method of synthesizing key intermediates for the production of camptothecin derivatives
#85Chemical process
#86Method for decarboxylating C—C cross-linking of carboxylic acids with carbon electrophiles
#87PYRANTHRONE TYPE COMPOUND, ORGANIC PHOTORECEPTOR, IMAGE FORMING METHOD AND IMAGE FORMING APPARATUS
#88NOVEL CURCUMIN ANALOGUES AND USES THEREOF
#89Curcumin analogues and uses thereof
#90Composition for diagnosing amyloid-related diseases
#91Screening Methods
#92Non-linear optically active molecules, their synthesis, and use
#93Organocatalysts and methods of use in chemical synthesis
#94Antiviral methods and compositions
#95Propofol analogs, process for their preparation, and methods of use
#96Detection of markers in nascent proteins
#97Detection of disease related genes
#98Method of using rhodium quinonoid catalysts
#99PROCESS FOR THE MANUFACTURING OF BETAMIMETICS
#100Substituted indoles and a process for preparing substituted indoles
#101Method for producing an optically active nitro compound
#102Hsp90 family protein inhibitors
#103Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
#104Photocleavable bioreactive agents
#105Method of synthesizing camptothecin-relating compounds
#106Bioreactive agents
#1071,3-Bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
#108Illudin analogs useful as antitumor agents
#1091-Adamantyl chalcones for the treatment of proliferative disorders
#110Process for producing 5-nitro-3,4-dihydro-1(H)-naphthalinone, 1,5-naphthalenediamine and 1,5-naphthalene diisocyanate
#111Process for producing 5-nitro-3,4-dihydro-1(2H)-naphthalinone, 1,5-naphthalenediamine and 1,5-naphthalene diisocyanate
#112Process for preparing encapsulated metalloporphyrin catalyst and process for oxidation of alcohols
#113Tubulin binding agents and corresponding prodrug constructs
#114Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia
#115Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
#116Pharmaceutically useful compounds
#117Detection of markers in nascent proteins
#118Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts
#119Esters with antimicrobial, bioresistant and fungal resistant properties
#120Ketones
#121Use of a solid hydrotalcite structure incorporating fluorides for basic catalysis of Michael or Knoevenagel reactions
#122Acylation of aromatic compounds
#123Curcumin analogues and uses thereof
#124Estrogen receptor modulators
#125Synthetic method and novel chemical compounds
#126Bioreactive agents
#127Combretastatin a-4 derivatives having antineoplastic activity
#1281-Adamantyl chalcones for the treatment of proliferative disorders